Theranostics Market By Disease 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Theranostics Market
Theranostics Market: By Disease (Neuro Disorders, Cancers and Cardiovascular diseases) & By Region (Asia-Pacific, Europe, North America, Others)-Forecast (2016-2021)
Report Code : HCR 0396
Published: 04 October, 2016   No. of pages: 125

  • Report Description
  • Table of Contents
  • Customization Options
Theranostics can be defined as the fusion of drug therapy and diagnostics to optimize effectiveness, safety, and streamline drug development. It is the combination of medical drugs with diagnostic tests and is also known as integrated medicine, pharmacodiagnostics, companion diagnostics, and Dx/Rx partnering. Theranostics involves association of diagnostics along with drug therapy in order to streamline the development of a drug which is more effective and cheaper. According to WHO, every year nearly 1o million new cases of cancer are being registered and cancer has become one of the major concern for the healthcare industry and it has become the need of the hour to develop an effective drug with minimum side effects which requires strong co-ordination between drug developers and diagnostic industry. Theranascostics is an emerging field, which is generating a strong interest from regulatory bodies and healthcare industries market.

 Theranostics Market

Geographically, North America dominates the theranostics market driven by best in class healthcare and pharmaceutical infrastructure, best in industry practices, strict regulation and high degree of adherence to the rules and guidelines. North America was followed by Europe and Asia-Pacific as second and third largests market for the theranostics market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, newer regulations implementations by governing bodies, and increasing awareness amongst population in developing nations such as China and India in this region.

This report identifies the global theranostics market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the theranostics market.

This report segments the theranostics market on the basis of diseases and regional market as follows:
  • Theranostics Market research report is classified on the basis of diseases. Some of the major diseases covered in this report are as follows: Neuro Disorders, Cancers and Cardiovascular diseases
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the theranostics market. Some of the major companies’ profiles in detail are as follows:
  • Abbott Laboratories
  • AmeriPath
  • Beckman Coulter
  • Dickinson & Company
  • BIOTEC Laboratories
1. Theranostics Market – Overview
2. Executive Summary
3. Theranostics Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Theranostics Market– Forces
   4.1. Drivers
      4.1.1. Improved cooperation between diagnostic and drug companies
      4.1.2. Increasing cases of cancer and cardiovascular diseases
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Theranostics Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Theranostics Market, By Diseases
   6.1. Neuro Disorders
   6.2. Cancers
   6.3. Cardiovascular Diseases
7. Theranostics Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Theranostics Market – Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Abbott Laboratories
   9.2. AmeriPath
   9.3. Beckman Coulter
   9.4. Dickinson & Company
   9.5. BIOTEC Laboratories
   9.6. Center for Disease Control and Prevention (CDC)
   9.7. Dade Behring
   9.8. Dianon Systems
   9.9. Dynacare Laboratories
   9.10. Enterix
   9.11. EntroGen
   9.12. Esoterix
   9.13. Focus Diagnostics
   9.14. Pfizer
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports